JP2022542140A5 - - Google Patents

Info

Publication number
JP2022542140A5
JP2022542140A5 JP2022505207A JP2022505207A JP2022542140A5 JP 2022542140 A5 JP2022542140 A5 JP 2022542140A5 JP 2022505207 A JP2022505207 A JP 2022505207A JP 2022505207 A JP2022505207 A JP 2022505207A JP 2022542140 A5 JP2022542140 A5 JP 2022542140A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
solvate
acceptable salt
tautomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022505207A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542140A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2020/050763 external-priority patent/WO2021012018A1/en
Publication of JP2022542140A publication Critical patent/JP2022542140A/ja
Publication of JP2022542140A5 publication Critical patent/JP2022542140A5/ja
Priority to JP2025100363A priority Critical patent/JP2025134819A/ja
Pending legal-status Critical Current

Links

JP2022505207A 2019-07-24 2020-07-24 阻害剤化合物 Pending JP2022542140A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025100363A JP2025134819A (ja) 2019-07-24 2025-06-16 阻害剤化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2019902614A AU2019902614A0 (en) 2019-07-24 Inhibitor compounds
AU2019902614 2019-07-24
PCT/AU2020/050763 WO2021012018A1 (en) 2019-07-24 2020-07-24 Inhibitor compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025100363A Division JP2025134819A (ja) 2019-07-24 2025-06-16 阻害剤化合物

Publications (2)

Publication Number Publication Date
JP2022542140A JP2022542140A (ja) 2022-09-29
JP2022542140A5 true JP2022542140A5 (cg-RX-API-DMAC7.html) 2023-07-31

Family

ID=74192564

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022505207A Pending JP2022542140A (ja) 2019-07-24 2020-07-24 阻害剤化合物
JP2025100363A Pending JP2025134819A (ja) 2019-07-24 2025-06-16 阻害剤化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025100363A Pending JP2025134819A (ja) 2019-07-24 2025-06-16 阻害剤化合物

Country Status (12)

Country Link
US (2) US12448371B2 (cg-RX-API-DMAC7.html)
EP (1) EP4003986A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022542140A (cg-RX-API-DMAC7.html)
KR (1) KR20220041843A (cg-RX-API-DMAC7.html)
CN (1) CN114450281B (cg-RX-API-DMAC7.html)
AU (1) AU2020316243B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022001270A2 (cg-RX-API-DMAC7.html)
CA (1) CA3144506A1 (cg-RX-API-DMAC7.html)
IL (1) IL290087B2 (cg-RX-API-DMAC7.html)
MX (1) MX2022000845A (cg-RX-API-DMAC7.html)
WO (1) WO2021012018A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202201680B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202213792D0 (en) * 2022-09-21 2022-11-02 Benevolentai Bio Ltd New compounds and method
CN117486792A (zh) * 2023-09-26 2024-02-02 北京四环科宝制药股份有限公司 尼可地尔中间体及其制备方法
US11912675B1 (en) 2023-10-11 2024-02-27 King Faisal University N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-3,4-dimethoxybenzimidamide as an antimicrobial compound
US11919872B1 (en) 2023-10-11 2024-03-05 King Faisal University N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound
US11891366B1 (en) 2023-10-12 2024-02-06 King Faisal University 4-methoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound
US11999706B1 (en) 2023-10-13 2024-06-04 King Faisal University 4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923661A (en) 1957-03-22 1960-02-02 Irwin Neisler And Co N-[2-(1-phenyl-propyl)]-2, 2, 2-trichloroethylidenimine
US5684018A (en) 1994-12-13 1997-11-04 Merck & Co., Inc. Acyloxyisopropyl carbamates as prodrugs for amine drugs
FI982268L (fi) 1998-10-20 2000-04-21 Tomi Jaervinen Ei-steroidaalisten anti-inflammatoristen karboksyylihappojen uudet pro drugit, niiden valmistus ja käyttö
MX2009012683A (es) * 2007-05-22 2009-12-11 Novartis Ag Benzamidas utiles como moduladores del receptor s1p.
WO2012164103A2 (en) * 2011-06-03 2012-12-06 Universität Zürich Blockers of the nogo-a s1pr pathway for the treatment of diseases characterized by neuronal damage and lack of subsequent repair
WO2015155738A2 (en) * 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
US9828351B2 (en) * 2014-06-26 2017-11-28 Monash University Enzyme interacting agents
WO2018112077A1 (en) 2016-12-13 2018-06-21 Centaurus Therapeutics Inhibitors of dihydroceramide desaturase for treating disease
CN108079303A (zh) * 2017-12-14 2018-05-29 广东药科大学 鞘氨醇激酶抑制剂在制备治疗肝纤维化药物中的应用

Similar Documents

Publication Publication Date Title
JP2020033357A5 (cg-RX-API-DMAC7.html)
ES2576497T3 (es) Compuesto de piperidina novedoso o sal del mismo
RU2430923C2 (ru) Тиазолилдигидрохиназолины
JP2014526500A5 (cg-RX-API-DMAC7.html)
JP2024512154A5 (cg-RX-API-DMAC7.html)
RU2011110908A (ru) Тиенопиримидины для фармацевтических композиций
JP2007508360A5 (cg-RX-API-DMAC7.html)
JP2016513661A5 (cg-RX-API-DMAC7.html)
JP2017531689A5 (cg-RX-API-DMAC7.html)
JP2014532716A5 (cg-RX-API-DMAC7.html)
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
RU2018133288A (ru) Комбинированные терапии для лечения спинальной мышечной атрофии
RU2014107000A (ru) Производные 3-гетероароиламинопропионовой кислоты и их применение в качестве лекарственных средств
JP2022501334A5 (cg-RX-API-DMAC7.html)
JP2019529487A5 (cg-RX-API-DMAC7.html)
RU2014106999A (ru) Замещенные производные 3-тиазолоаминопропионовой кислоты и их применение в качестве фармацевтических препаратов
RU2006134022A (ru) Производные индазола и содержащие их фармацевтические композиции
JP2025509846A5 (cg-RX-API-DMAC7.html)
JP2015502371A5 (cg-RX-API-DMAC7.html)
JP2024501257A5 (cg-RX-API-DMAC7.html)
RU2013139352A (ru) Аминозамещенные производные 3-гетероароиламинопропионовой кислоты и их применение в качестве фармацевтических средств
JP2025032222A (ja) Bcn057及びbcn512を用いる治療方法
JP2009509928A5 (cg-RX-API-DMAC7.html)
JP2009501745A5 (cg-RX-API-DMAC7.html)
CN107629022B (zh) 一种抗菌增效剂及其制法和用途